Preterm labour: association between labour physiology, tocolysis and prevention

Bibliography

• Report of a WHO Expert Committee. The prevention of perinatal mortality and morbidity. World Health Organ Tech Rep Ser 1970;457:1-60
   PubMedGoogle Scholar
• Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75-84
   PubMed Web of Science ®Google Scholar
• Moutquin JM. Classification and heterogeneity of preterm birth. BJOG 2003;110(Suppl 20):30-3
   PubMed Web of Science ®Google Scholar
• Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med 1999;341(9):660-6
   PubMed Web of Science ®Google Scholar
• Chanrachakul B. Ion channels: new targets for the next generation of tocolytics agents. J Med Assoc Thai 2006;89(Suppl 4):S178-83
   PubMedGoogle Scholar
• Tribe RM. Regulation of human myometrial contractility during pregnancy and labour: are calcium homeostatic pathways important? Exp Physiol 2001;86(2):247-54
   PubMed Web of Science ®Google Scholar
• Sperelakis N, Inoue Y, Ohya Y. Fast Na+ channels and slow Ca2+ current in smooth muscle from pregnant rat uterus. Mol Cell Biochem 1992;114(1-2):79-89
   PubMed Web of Science ®Google Scholar
• Young RC, Herndon-Smith L. Characterization of sodium channels in cultured human uterine smooth muscle cells. Am J Obstet Gynecol 1991;164(1 Pt 1):175-81
   PubMed Web of Science ®Google Scholar
• Tong WC, Choi CY, Kharche S, et al. A computational model of the ionic currents, Ca2+ dynamics and action potentials underlying contraction of isolated uterine smooth muscle. PLoS One 2011;6(4):e18685
   PubMedGoogle Scholar
• Ohkubo T, Kawarabayashi T, Inoue Y, et al. Differential expression of L- and T-type calcium channels between longitudinal and circular muscles of the rat myometrium during pregnancy. Gynecol Obstet Invest 2005;59(2):80-5
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Inoue Y, Kawarabayashi T, et al. Identification and electrophysiological characteristics of isoforms of T-type calcium channel Ca(v)3.2 expressed in pregnant human uterus. Cell Physiol Biochem 2005;16(4-6):245-54
   PubMed Web of Science ®Google Scholar
• Asokan KT, Sarkar SN, Mishra SK, et al. Effects of mibefradil on uterine contractility. Eur J Pharmacol 2002;455(1):65-71
   PubMed Web of Science ®Google Scholar
• Meera P, Wallner M, Jiang Z, et al. A calcium switch for the functional coupling between alpha (hslo) and beta subunits (Kv,cabeta) of maxi K channels. FEBS Lett 1996;385(1-2):127-8
   PubMed Web of Science ®Google Scholar
• Chanrachakul B, Matharoo-Ball B, Turner A, et al. Immunolocalization and protein expression of the alpha subunit of the large-conductance calcium-activated potassium channel in human myometrium. Reproduction 2003;126(1):43-8
   PubMed Web of Science ®Google Scholar
• Chanrachakul B, Broughton Pipkin F, Khan RN. Contribution of coupling between human myometrial beta2-adrenoreceptor and the BK(Ca) channel to uterine quiescence. Am J Physiol Cell Physiol 2004;287(6):C1747-52
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Smooth muscle cell calcium activation mechanisms. J Physiol 2008;586(21):5047-61
   PubMed Web of Science ®Google Scholar
• DiPolo R, Beauge L. Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions. Physiol Rev 2006;86(1):155-203
   PubMed Web of Science ®Google Scholar
• Carafoli E, Santella L, Branca D, et al. Generation, control, and processing of cellular calcium signals. Crit Rev Biochem Mol Biol 2001;36(2):107-260
   PubMed Web of Science ®Google Scholar
• Morgan JM, De Smedt H, Gillespie JI. Identification of three isoforms of the InsP3 receptor in human myometrial smooth muscle. Pflugers Arch 1996;431(5):697-705
   PubMed Web of Science ®Google Scholar
• Lynn S, Morgan JM, Lamb HK, et al. Isolation and partial cloning of ryanodine-sensitive Ca2+ release channel protein isoforms from human myometrial smooth muscle. FEBS Lett 1995;372(1):6-12
   PubMed Web of Science ®Google Scholar
• Martin C, Hyvelin JM, Chapman KE, et al. Pregnant rat myometrial cells show heterogeneous ryanodine- and caffeine-sensitive calcium stores. Am J Physiol 1999;277(2 Pt 1):C243-52
   PubMed Web of Science ®Google Scholar
• Arnaudeau S, Lepretre N, Mironneau J. Oxytocin mobilizes calcium from a unique heparin-sensitive and thapsigargin-sensitive store in single myometrial cells from pregnant rats. Pflugers Arch 1994;428(1):51-9
   PubMed Web of Science ®Google Scholar
• Burdyga T, Wray S, Noble K. In situ calcium signaling: no calcium sparks detected in rat myometrium. Ann NY Acad Sci 2007;1101:85-96
   PubMed Web of Science ®Google Scholar
• Tribe RM, Moriarty P, Poston L. Calcium homeostatic pathways change with gestation in human myometrium. Biol Reprod 2000;63(3):748-55
   PubMed Web of Science ®Google Scholar
• Taggart MJ, Wray S. Contribution of sarcoplasmic reticular calcium to smooth muscle contractile activation: gestational dependence in isolated rat uterus. J Physiol 1998;511(Pt 1):133-44
   PubMed Web of Science ®Google Scholar
• Matthew A, Kupittayanant S, Burdyga T, et al. Characterization of contractile activity and intracellular Ca2+ signalling in mouse myometrium. J Soc Gynecol Investig 2004;11(4):207-12
   PubMedGoogle Scholar
• Kupittayanant S, Luckas MJ, Wray S. Effect of inhibiting the sarcoplasmic reticulum on spontaneous and oxytocin-induced contractions of human myometrium. BJOG 2002;109(3):289-96
   PubMed Web of Science ®Google Scholar
• Shmigol AV, Eisner DA, Wray S. The role of the sarcoplasmic reticulum as a Ca2+ sink in rat uterine smooth muscle cells. J Physiol 1999;520 Pt 1:153-63
   PubMed Web of Science ®Google Scholar
• Korenman SG, Krall JF. The role of cyclic AMP in the regulation of smooth muscle cell contraction in the uterus. Biol Reprod 1977;16(1):1-17
   PubMed Web of Science ®Google Scholar
• Yuan W, Lopez Bernal A. Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth 2007;7(Suppl 1):S10
   PubMedGoogle Scholar
• Scheid CR, Honeyman TW, Fay FS. Mechanism of beta-adrenergic relaxation of smooth muscle. Nature 1979;277(5691):32-6
   PubMed Web of Science ®Google Scholar
• Kofinas AD, Rose JC, Meis PJ. Changes in cyclic adenosine monophosphate-phosphodiesterase activity in nonpregnant and pregnant human myometrium. Am J Obstet Gynecol 1987;157(3):733-8
   PubMed Web of Science ®Google Scholar
• Kofinas AD, Rose JC, Koritnik DR, et al. Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity. J Reprod Med 1990;35(11):1045-50
   PubMed Web of Science ®Google Scholar
• Mehats C, Oger S, Leroy MJ. Cyclic nucleotide phosphodiesterase-4 inhibitors: a promising therapeutic approach to premature birth? Eur J Obstet Gynecol Reprod Biol 2004;117(Suppl 1):S15-17
   PubMedGoogle Scholar
• Mehats C, Schmitz T, Oger S, et al. PDE4 as a target in preterm labour. BMC Pregnancy Childbirth 2007;7(Suppl 1):S12
   PubMedGoogle Scholar
• Word RA, Li XH, Hnat M, et al. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 2007;25(1):69-79
   PubMed Web of Science ®Google Scholar
• Leppert PC. Anatomy and physiology of cervical ripening. Clin Obstet Gynecol 1995;38(2):267-79
   PubMed Web of Science ®Google Scholar
• Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab 2010;21(6):353-61
   PubMed Web of Science ®Google Scholar
• Yount SM, Lassiter N. The pharmacology of prostaglandins for induction of labor. J Midwifery Womens Health 2013;58(2):133-44; quiz 238-9
   PubMed Web of Science ®Google Scholar
• Weiss G, Goldsmith LT. Mechanisms of relaxin-mediated premature birth. Ann NY Acad Sci 2005;1041:345-50
   PubMed Web of Science ®Google Scholar
• Zhao L, Samuel CS, Tregear GW, et al. Collagen studies in late pregnant relaxin null mice. Biol Reprod 2000;63(3):697-703
   PubMed Web of Science ®Google Scholar
• Obara M, Hirano H, Ogawa M, et al. Changes in molecular weight of hyaluronan and hyaluronidase activity in uterine cervical mucus in cervical ripening. Acta Obstet Gynecol Scand 2001;80(6):492-6
   PubMed Web of Science ®Google Scholar
• Holt R, Timmons BC, Akgul Y, et al. The molecular mechanisms of cervical ripening differ between term and preterm birth. Endocrinology 2011;152(3):1036-46
   PubMed Web of Science ®Google Scholar
• Larsen B, Hwang J. Progesterone interactions with the cervix: translational implications for term and preterm birth. Infect Dis Obstet Gynecol 2011;2011:353297
   PubMedGoogle Scholar
• Romero R, Mazor M, Wu YK, et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988;12(4):262-79
   PubMed Web of Science ®Google Scholar
• Romero R, Espinoza J, Goncalves LF, et al. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006;11(5):317-26
   PubMed Web of Science ®Google Scholar
• Keelan JA, Blumenstein M, Helliwell RJ, et al. Cytokines, prostaglandins and parturition–a review. Placenta 2003;24(Suppl A):S33-46
   PubMed Web of Science ®Google Scholar
• Mitchell MD, Strickland D, Brennecke S, et al. Parturition as an inflammatory Reaction. New Aspects of Arachidonic Acid Metabolism and Human Parturition Initiation of Parturition: Prevention of Prematurity, (Report of the Fourth ROSS CONFERENCE on Obstetric Research) 1983:145-9.
   Google Scholar
• King JF, Flenady VJ, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst Rev 2003(1):CD002255
   Google Scholar
• Haas DM, Caldwell DM, Kirkpatrick P, et al. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012;345:e6226
   PubMed Web of Science ®Google Scholar
• Phillippe M. Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions. Biochem Biophys Res Commun 1998;252(2):502-7
   PubMed Web of Science ®Google Scholar
• Tchilinguirian NG, Najem R, Sullivan GB, et al. The use of ritodrine and magnesium sulfate in the arrest of premature labor. Int J Gynaecol Obstet 1984;22(2):117-23
   PubMed Web of Science ®Google Scholar
• Terrone DA, Rinehart BK, Kimmel ES, et al. A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. Am J Obstet Gynecol 2000;182(6):1477-82
   PubMed Web of Science ®Google Scholar
• Nassar AH, Sakhel K, Maarouf H, et al. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis. Acta Obstet Gynecol Scand 2006;85(9):1099-103
   PubMed Web of Science ®Google Scholar
• Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database Syst Rev 2002;(4):CD001060
   Google Scholar
• Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004;(4):CD004352
   Google Scholar
• Lamont RF. The pathophysiology of pulmonary oedema with the use of beta-agonists. BJOG 2000;107(4):439-44
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Mochizuki M, Moriyama T, et al. Pulmonary edema as an acute complication of ritodrine therapy in the presence of maternal intrauterine infection. Clin Exp Obstet Gynecol 1998;25(3):99-100
   PubMedGoogle Scholar
• Weintraub Z, Solovechick M, Reichman B, et al. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2001;85(1):F13-17
   PubMed Web of Science ®Google Scholar
• Ozcan T, Turan C, Ekici E, et al. Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage. Gynecol Obstet Invest 1995;39(1):60-2
   PubMed Web of Science ®Google Scholar
• Palta M, Sadek M, Lim TS, et al. Association of tocolytic therapy with antenatal steroid administration and infant outcomes. Newborn Lung Project. Am J Perinatol 1998;15(2):87-92
   PubMed Web of Science ®Google Scholar
• Groome LJ, Goldenberg RL, Cliver SP, et al. Neonatal periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of Dimes Multicenter Study Group. Am J Obstet Gynecol 1992;167(4 Pt 1):873-9
   PubMed Web of Science ®Google Scholar
• Papatsonis DN, Kok JH, van Geijn HP, et al. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 2000;95(4):477-81
   PubMed Web of Science ®Google Scholar
• Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Rev 2005;(3):CD004452
   Google Scholar
• Salim R, Garmi G, Nachum Z, et al. Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial. Obstet Gynecol 2012;120(6):1323-31
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Yamasaki A, Segi E, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997;277(5326):681-3
   PubMed Web of Science ®Google Scholar
• Stika CS, Gross GA, Leguizamon G, et al. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 2002;187(3):653-60
   PubMed Web of Science ®Google Scholar
• Khanprakob T, Laopaiboon M, Lumbiganon P, et al. Cyclo-oxygenase (COX) inhibitors for preventing preterm labour. Cochrane Database Syst Rev 2012;10:CD007748
   PubMedGoogle Scholar
• Abou-Ghannam G, Usta IM, Nassar AH. Indomethacin in pregnancy: applications and safety. Am J Perinatol 2012;29(3):175-86
   PubMed Web of Science ®Google Scholar
• Haas DM, Imperiale TF, Kirkpatrick PR, et al. Tocolytic therapy: a meta-analysis and decision analysis. Obstet Gynecol 2009;113(3):585-94
   PubMed Web of Science ®Google Scholar
• Abramovici A, Cantu J, Jenkins SM. Tocolytic therapy for acute preterm labor. Obstet Gynecol Clin North Am 2012;39(1):77-87
   PubMed Web of Science ®Google Scholar
• Romero R, Nicolaides K, Conde-Agudelo A, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012;206(2):124.e1-19
   PubMed Web of Science ®Google Scholar
• Dodd JM, Jones L, Flenady V, et al. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database Syst Rev 2013;7:CD004947
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Stampalija T, Roberts D, et al. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev 2012;4:CD008991
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R, Nicolaides K, et al. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol 2013;208(1):42.e1-42.e18
   PubMed Web of Science ®Google Scholar
• Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev 2013;5:CD007873
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Owen J, Carreras Moratonas E, et al. Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol 2013;41(2):146-51
   PubMed Web of Science ®Google Scholar
• Sibai B. Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor. 2009. Available from: http://clinicaltrials.gov/show/NCT00306462
   Google Scholar
• Heida K. Assessment of Perinatal Outcome by use of SpecificTocolytics in Early Labour. - APOSTEL III. 2011-2013. Available from: http://apps.who.int/trialsearch/Trial.aspx?TrialID=NTR2947
   Google Scholar
• Larque E, Gil-Sanchez A, Prieto-Sanchez MT, et al. Omega 3 fatty acids, gestation and pregnancy outcomes. Br J Nutr 2012;107(Suppl 2):S77-84
   PubMedGoogle Scholar
• Ramakrishnan U, Stein AD, Parra-Cabrera S, et al. Effects of docosahexaenoic acid supplementation during pregnancy on gestational age and size at birth: randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull 2010;31(2 Suppl):S108-16
   PubMed Web of Science ®Google Scholar
• Rogers LK, Valentine CJ, Keim SA. DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 2013;70(1):13-19
   PubMed Web of Science ®Google Scholar
• Carlson SE, Colombo J, Gajewski BJ, et al. DHA supplementation and pregnancy outcomes. Am J Clin Nutr 2013;97(4):808-15
   PubMed Web of Science ®Google Scholar
• Carlson SE, Colombo J. DHA Supplementation and Pregnancy Outcome. 2012. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00266825?term=NCT00266825&rank=1
   Google Scholar
• Khambhaita S, Zjou S. Omega-3 fats to reduce the incidence of prematurity in healthy women with a singleton or multiple pregnancy less than 20 weeks gestation. 2013. Available from: http://apps.who.int/trialsearch/Trial.aspx?TrialID=ACTRN12613001142729
   Google Scholar